Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Adamas Pharmaceuticals stock | $8.05

Learn how to easily invest in Adamas Pharmaceuticals stock.

Adamas Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Adamas Pharmaceuticals shares (ADMS) are listed on the NASDAQ and all prices are listed in US Dollars. Adamas Pharmaceuticals employs 138 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Adamas Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADMS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Adamas Pharmaceuticals stock price (NASDAQ: ADMS)

Use our graph to track the performance of ADMS stocks over time.

Adamas Pharmaceuticals shares at a glance

Information last updated 2021-10-23.
Latest market close$8.05
52-week range$2.96 - $9.15
50-day moving average $5.71
200-day moving average $5.21
Wall St. target price$7.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.60

Buy Adamas Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Adamas Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adamas Pharmaceuticals price performance over time

Historical closes compared with the close of $8.05 from 2021-10-25

1 week (2021-10-16) N/A
1 month (2021-09-27) 55.41%
3 months (2021-07-27) 67.71%
6 months (2021-04-27) 35.07%
1 year (2020-10-26) 130.66%
2 years (2019-10-25) 104.83%
3 years (2018-10-26) 17.2
5 years (2016-10-26) 14.35

Adamas Pharmaceuticals financials

Revenue TTM $82.5 million
Gross profit TTM $72.4 million
Return on assets TTM -16.4%
Return on equity TTM 0%
Profit margin -66.82%
Book value $0.13
Market capitalisation $366 million

TTM: trailing 12 months

Shorting Adamas Pharmaceuticals shares

There are currently 2.4 million Adamas Pharmaceuticals shares held short by investors – that's known as Adamas Pharmaceuticals's "short interest". This figure is 5.9% down from 2.5 million last month.

There are a few different ways that this level of interest in shorting Adamas Pharmaceuticals shares can be evaluated.

Adamas Pharmaceuticals's "short interest ratio" (SIR)

Adamas Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Adamas Pharmaceuticals shares currently shorted divided by the average quantity of Adamas Pharmaceuticals shares traded daily (recently around 151868.27231856). Adamas Pharmaceuticals's SIR currently stands at 15.57. In other words for every 100,000 Adamas Pharmaceuticals shares traded daily on the market, roughly 15570 shares are currently held short.

However Adamas Pharmaceuticals's short interest can also be evaluated against the total number of Adamas Pharmaceuticals shares, or, against the total number of tradable Adamas Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adamas Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Adamas Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0582% of the tradable shares (for every 100,000 tradable Adamas Pharmaceuticals shares, roughly 58 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Adamas Pharmaceuticals.

Find out more about how you can short Adamas Pharmaceuticals stock.

Adamas Pharmaceuticals share dividends

We're not expecting Adamas Pharmaceuticals to pay a dividend over the next 12 months.

Adamas Pharmaceuticals share price volatility

Over the last 12 months, Adamas Pharmaceuticals's shares have ranged in value from as little as $2.96 up to $9.15. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamas Pharmaceuticals's is 2.6042. This would suggest that Adamas Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Adamas Pharmaceuticals overview

Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. It offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, as well as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes; and OSMOLEX ER, an extended release tablet to treat Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. The company is also developing ADS-4101, which has completed two Phase 1b studies for treating partial onset seizures in patients with epilepsy. In addition, it offers NAMZARIC and NAMENDA XR, a memantine hydrochloride extended release and donepezil hydrochloride capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Adamas Pharmaceuticals is owned by insiders or institutions?
Currently 1.747% of Adamas Pharmaceuticals shares are held by insiders and 80.538% by institutions.
How many people work for Adamas Pharmaceuticals?
Latest data suggests 138 work at Adamas Pharmaceuticals.
When does the fiscal year end for Adamas Pharmaceuticals?
Adamas Pharmaceuticals's fiscal year ends in December.
Where is Adamas Pharmaceuticals based?
Adamas Pharmaceuticals's address is: 1900 Powell Street, EmeryVille, CA, United States, 94608
What is Adamas Pharmaceuticals's ISIN number?
Adamas Pharmaceuticals's international securities identification number is: US00548A1060
What is Adamas Pharmaceuticals's CUSIP number?
Adamas Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00548A106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site